HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/6/H2441    most recent 00005.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Bernstein, D. Articles by Kobilka, B. K. Search for Related Content PubMed PubMed Citation Articles by Bernstein, D. Articles by Kobilka, B. K.

Differential cardioprotective/cardiotoxic effects mediated by -adrenergic receptor subtypes

Departments of ¹Pediatrics, ²Pathology, and ³Molecular and Cellular Physiology, Stanford University, Stanford, California

Submitted 5 January 2005 ; accepted in final form 13 July 2005

Recent data suggest that -adrenergic receptor subtypes couple differentially to signaling pathways regulating cardiac function vs. cardiac remodeling. To dissect the roles of 1- vs. 2-receptors in the pathogenesis of cardiomyopathy, doxorubicin was administered to 1, 2, and 1/2 knockout (^–/–) and wild-type mice. Expression and activation of MAPKs were measured. Wild-type and 1^–/– mice showed no acute cardiovascular effects, whereas 2^–/– mice all died within 30 min. The additional deletion of the 1-receptor (1/2^–/–) totally rescued this toxicity. 2^–/– mice developed decreased contractile function, hypotension, QTc prolongation, and ST segment changes and a 20-fold increase in p38 MAPK activity not seen in the other genotypes. The MAPK inhibitor SB-203580 rescued 2^–/– mice from this acute toxicity. The enhanced toxicity in 2^–/– mice was also recapitulated in wild-type mice with the 2-selective antagonist ICI-118,551, although the rescue effect of the 1-deletion was not recapitulated using the 1-selective antagonist metoprolol or the nonselective -antagonist propranolol. These data suggest that 2-adrenergic receptors play a cardioprotective role in the pathogenesis of cardiomyopathy, whereas 1-adrenergic receptors mediate at least some of the acute cardiotoxicity of anthracyclines. Differential activation of MAPK isoforms, previously shown in vitro to regulate -agonist as well as doxorubicin cardiotoxicity, appears to play a role in mediating the differential effects of these -adrenergic receptor subtypes in vivo.

cardiomyopathy; anthracycline; adrenergic receptor; cell signaling; -blocker; mitogen-activated protein kinase

This article has been cited by other articles:

				G. Fajardo and D. Bernstein Endocannabinoid Inhibition: A New Cardioprotective Strategy Against Doxorubicin Cardiotoxicity J. Am. Coll. Cardiol., August 7, 2007; 50(6): 537 - 539. [Full Text] [PDF]

				O. G. Shcherbakova, C. M. Hurt, Y. Xiang, M. L. Dell'Acqua, Q. Zhang, R. W. Tsien, and B. K. Kobilka Organization of {beta}-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes J. Cell Biol., February 12, 2007; 176(4): 521 - 533. [Abstract] [Full Text] [PDF]